Risk of incident diabetes after COVID-19 infection: A systematic review and meta-analysis

Song, XP; Ge, L (通讯作者),Lanzhou Univ, Evidence Based Social Sci Res Ctr, Sch Publ Hlth, 199 Donggang West Rd, Lanzhou 730000, Peoples R China.
2022
Background: COVID-19 might be a risk factor for various chronic diseases. However, the association between COVID-19 and the risk of incident diabetes remains unclear. We aimed to meta-analyze evidence on the relative risk of incident diabetes in patients with COVID-19.Methods: In this systematic review and meta-analysis, the Embase, PubMed, CENTRAL, and Web of Science databases were searched from December 2019 to June 8, 2022. We included cohort studies that provided data on the number, proportion, or relative risk of diabetes after confirming the COVID-19 diagnosis. Two reviewers independently screened studies for eligibility, extracted data, and assessed risk of bias. We used a random-effects meta-analysis to pool the relative risk with corresponding 95 % confidence intervals. Prespecified subgroup and meta-regression analyses were conducted to explore the potential influencing factors. We converted the relative risk to the absolute risk difference to present the evidence. This study was registered in advance (PROSPERO CRD42022337841). Main findings: Ten articles involving 11 retrospective cohorts with a total of 47.1 million participants proved eligible. We found a 64 % greater risk (RR = 1.64, 95%CI: 1.51 to 1.79) of diabetes in patients with COVID-19 compared with non-COVID-19 controls, which could increase the number of diabetes events by 701 (558 more to 865 more) per 10,000 persons. We detected significant subgroup effects for type of diabetes and sex. Type 2 diabetes has a higher relative risk than type 1. Moreover, men may be at a higher risk of overall diabetes than women. Sensitivity analysis confirmed the robustness of the results. No evidence was found for publication bias.Conclusions: COVID-19 is strongly associated with the risk of incident diabetes, including both type 1 and type 2 diabetes. We should be aware of the risk of developing diabetes after COVID-19 and prepare for the associated health problems, given the large and growing number of people infected with COVID-19. However, the body of evidence still needs to be strengthened.
METABOLISM-CLINICAL AND EXPERIMENTAL
卷号:137
ISSN:0026-0495|收录类别:SCIE
DOI
10.1016/j.metabol.2022.155330
来源机构
Lanzhou University; Lanzhou University; Nanjing University of Chinese Medicine; Lanzhou University; Lanzhou University; Air Force Military Medical University; Lanzhou University
EISSN
1532-8600
网络首发日期
2022-10
出版年
2022
语种
英语
WOS学科分类
Endocrinology & Metabolism
被引频次(WOS)
0
180天使用计数
8
2013以来使用计数
8
被引更新日期
2023-02-19
关联机构
兰州大学循证社会科学中心
关键词
COVID-19 Diabetes Public health Long COVID